{"product_id":"dual-diagnosis-isbn-9781405180092","title":"Dual Diagnosis","description":"\u003cp\u003e\u003ci\u003eDual Diagnosis: Practice in Context\u003c\/i\u003e is a practical evidence-based guide for practitioners working in multi-disciplinary mental health and substance misuse service settings. Divided into three sections, this comprehensive and international text first explores the contemporary contextual issues surrounding the subject area.  It then goes on to review dual diagnosis in some of the ‘special’ populations (including people diagnosed with personality disorders, women, young people, and older adults) and contemporary issues (e.g. crystal methamphetamine and mental health).  \u003cbr\u003ePart three reviews the development of international service responses to dual diagnosis and discusses the development and commissioning of service models, research and practice development. The text concludes with a chapter outlining priorities for the development of interventions, service approaches, research and education.\u003c\/p\u003e \u003cp\u003eKEY FEATURES:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eA authoritative  in-depth review of both theoretical, clinical and policy issues within a single text\u003c\/li\u003e \u003cli\u003eDraws together a range of established contributors from a variety of disciplines, including mental health nurses, occupational therapists, social workers and psychiatrists\u003c\/li\u003e \u003cli\u003eInternational in focus, with contributors from the UK, USA, Europe and Australia\u003c\/li\u003e \u003c\/ul\u003e  Contributors.  \u003cp\u003eForeword.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1 Contemporary Context.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Definition, Recognition and Assessment \u003ci\u003e(Olive McKeown).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eDefinition and terminology.\u003c\/p\u003e \u003cp\u003eGeneral considerations in the recognition and assessment of dual diagnosis.\u003c\/p\u003e \u003cp\u003eHow significant is the problem of dual diagnosis?\u003c\/p\u003e \u003cp\u003eRecognition and assessment.\u003c\/p\u003e \u003cp\u003eHypotheses.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e2 Explanatory Models for Dual Diagnosis \u003ci\u003e(Peter Phillips and Sonia Johnson).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eIs substance misuse more prevalent among people with psychotic illnesses than in the general population?\u003c\/p\u003e \u003cp\u003eWhich problem generally develops first in dual diagnosis?\u003c\/p\u003e \u003cp\u003eDoes dual diagnosis have a neurobiological basis?\u003c\/p\u003e \u003cp\u003eIs dual diagnosis mediated by personality disorder?\u003c\/p\u003e \u003cp\u003eDo people with schizophrenia use substances as a form of self-medication?\u003c\/p\u003e \u003cp\u003eHave changes in the care and social circumstances of people with schizophrenia, particularly deinstitutionalisation, led to a rise in substance misuse in this population?\u003c\/p\u003e \u003cp\u003eDo the social situations and social difficulties of people with schizophrenia lead to substance use?\u003c\/p\u003e \u003cp\u003eDo people with schizophrenia tend to begin using drugs and alcohol within mental health service settings or in the company of other users of such services?\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e3 Consumer Perspectives \u003ci\u003e(David Webb).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eHuman experience and medicine.\u003c\/p\u003e \u003cp\u003eDiagnosis, treatment and human rights.\u003c\/p\u003e \u003cp\u003eTwo worlds.\u003c\/p\u003e \u003cp\u003eSignificant contrasts.\u003c\/p\u003e \u003cp\u003eDiagnosis.\u003c\/p\u003e \u003cp\u003eTreatment.\u003c\/p\u003e \u003cp\u003eDual diagnosis and policy.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2 Common Presentations and Special Populations.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e4 Risk Assessment and Dual Diagnosis \u003ci\u003e(Lisa Reynolds and Jenny Oates).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eClinical risk assessment.\u003c\/p\u003e \u003cp\u003ePrinciples of risk assessment and management.\u003c\/p\u003e \u003cp\u003eThe process of risk assessment and management.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e5 Reducing Drug-Related Harm Among Mentally Ill People \u003ci\u003e(Peter Phillips).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eInterventions and approaches.\u003c\/p\u003e \u003cp\u003eHarm reduction.\u003c\/p\u003e \u003cp\u003eUsing harm reduction approaches with mentally ill individuals.\u003c\/p\u003e \u003cp\u003eDual diagnosis and harm reduction: the future?\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e6 Motivational Interviewing \u003ci\u003e(Chris Glover).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eWhat is MI?\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e7 Psychological Interventions \u003ci\u003e(Patrick Callaghan and David Jones).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eThe nature and type of psychological interventions.\u003c\/p\u003e \u003cp\u003eThe evidence for psychological interventions in dual diagnosis.\u003c\/p\u003e \u003cp\u003eIndividual therapies.\u003c\/p\u003e \u003cp\u003eGroup therapies.\u003c\/p\u003e \u003cp\u003eCognitive behaviour therapy and relapse prevention.\u003c\/p\u003e \u003cp\u003eFamily interventions.\u003c\/p\u003e \u003cp\u003eContingency management.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e8 Alcohol and Mood Disorders \u003ci\u003e(Julie Attenborough).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eHarm, alcohol and mental illness.\u003c\/p\u003e \u003cp\u003ePresentation: alcohol and mental illness.\u003c\/p\u003e \u003cp\u003eMedication and dual diagnosis.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e9 Polysubstance Use and Personality Disorder \u003ci\u003e(Simon McArdle).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003ePrevalence.\u003c\/p\u003e \u003cp\u003eService delivery.\u003c\/p\u003e \u003cp\u003eWhat is personality disorder?\u003c\/p\u003e \u003cp\u003eTreatment and intervention approaches.\u003c\/p\u003e \u003cp\u003eAssessment.\u003c\/p\u003e \u003cp\u003eStages of change.\u003c\/p\u003e \u003cp\u003eTherapeutic principles.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e10 Older People and Dual Diagnosis \u003ci\u003e(Sue Excell).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eAn increasing population.\u003c\/p\u003e \u003cp\u003ePolicy framework.\u003c\/p\u003e \u003cp\u003eMedia representation of information on alcohol.\u003c\/p\u003e \u003cp\u003ePerception of old age.\u003c\/p\u003e \u003cp\u003eAlcohol use in older people.\u003c\/p\u003e \u003cp\u003eComplications of excessive alcohol use.\u003c\/p\u003e \u003cp\u003eAssessment and screening.\u003c\/p\u003e \u003cp\u003eUnder-reporting.\u003c\/p\u003e \u003cp\u003eOver-the-counter medication (OTC).\u003c\/p\u003e \u003cp\u003ePrescribed medication.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e11 Stimulant Use and Psychosis \u003ci\u003e(Lorna Saunder).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eStimulant use in the United Kingdom.\u003c\/p\u003e \u003cp\u003eStimulants and drug-induced psychosis.\u003c\/p\u003e \u003cp\u003eStimulants and mental illness.\u003c\/p\u003e \u003cp\u003eStimulants and their use by people with existing psychotic illnesses.\u003c\/p\u003e \u003cp\u003eImplications for practice.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e12 Women and Dual Diagnosis \u003ci\u003e(Julie Winnington).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eGender differences in dual diagnosis.\u003c\/p\u003e \u003cp\u003eThe impact of dual diagnosis on families.\u003c\/p\u003e \u003cp\u003eDual diagnosis and domestic violence.\u003c\/p\u003e \u003cp\u003eDual diagnosis within the female prison service.\u003c\/p\u003e \u003cp\u003eA case for gender-specific services.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e13 Drug-Induced Psychosis \u003ci\u003e(Hülya Bilgin, Murat Soncul and Peter Phillips).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eDual diagnosis: a common problem.\u003c\/p\u003e \u003cp\u003eThe relationship between substance use and psychosis: aetiology.\u003c\/p\u003e \u003cp\u003eA model of relationships between psychotic illness and drug and alcohol use.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e14 Cannabis Use and Psychosis \u003ci\u003e(Liz Hughes).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eWhat is cannabis?\u003c\/p\u003e \u003cp\u003eHow is it used?\u003c\/p\u003e \u003cp\u003eLegal issues.\u003c\/p\u003e \u003cp\u003eHow it affects the user.\u003c\/p\u003e \u003cp\u003ePsychological effects.\u003c\/p\u003e \u003cp\u003ePhysical effects.\u003c\/p\u003e \u003cp\u003eSafety issues.\u003c\/p\u003e \u003cp\u003eThe links between cannabis and psychosis.\u003c\/p\u003e \u003cp\u003eInterventions for cannabis and psychosis.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e15 Methamphetamine and Mental Health \u003ci\u003e(Melinda Campopiano).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eInitiation and continuation of methamphetamine use: missed opportunities.\u003c\/p\u003e \u003cp\u003eMethamphetamine and mental health: intoxication, withdrawal and psychiatric illness.\u003c\/p\u003e \u003cp\u003eMethamphetamine addiction: treatment and outcomes.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003eAcknowledgements.\u003c\/p\u003e \u003cp\u003e16 Public Health and Dual Diagnosis \u003ci\u003e(Linda Bailey).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eEpidemiology.\u003c\/p\u003e \u003cp\u003eCausal relationship.\u003c\/p\u003e \u003cp\u003eTreatment for BBV.\u003c\/p\u003e \u003cp\u003eOther co-infections.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e17 Comorbidity or Complexity: A Primary Care Perspective on Dual Diagnosis \u003ci\u003e(John Budd).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003ePolicy framework.\u003c\/p\u003e \u003cp\u003eEpidemiology.\u003c\/p\u003e \u003cp\u003eKey features of general practice care.\u003c\/p\u003e \u003cp\u003ePhysical health care.\u003c\/p\u003e \u003cp\u003eMental health and substance misuse care.\u003c\/p\u003e \u003cp\u003eLimitations and potential in primary care.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3 International Perspectives, Policy and Development.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e18 Dual Diagnosis – North America \u003ci\u003e(Theodora Sirota and Kathleen Leo).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003ePrevalence.\u003c\/p\u003e \u003cp\u003eHistorical context.\u003c\/p\u003e \u003cp\u003eSocio-cultural and public policy considerations.\u003c\/p\u003e \u003cp\u003eApproaches to treatment.\u003c\/p\u003e \u003cp\u003eResearch.\u003c\/p\u003e \u003cp\u003eIssues and challenges.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e19 Dual Diagnosis – Australasia \u003ci\u003e(Gary Croton).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eDrivers for system change.\u003c\/p\u003e \u003cp\u003eConsumer and carer demand.\u003c\/p\u003e \u003cp\u003ePrevalence.\u003c\/p\u003e \u003cp\u003eHarms and unwanted outcomes strongly associated with dual diagnosis.\u003c\/p\u003e \u003cp\u003eOpportunity to provide more effective treatment of ‘target’ disorders via improved recognition and more effective responses to co-occurring disorders.\u003c\/p\u003e \u003cp\u003eBarriers to better outcomes for persons with dual diagnosis.\u003c\/p\u003e \u003cp\u003eIndigenous Australians.\u003c\/p\u003e \u003cp\u003eRural and remote regions of Australia.\u003c\/p\u003e \u003cp\u003eAustralia’s responses to dual diagnosis.\u003c\/p\u003e \u003cp\u003eStructure of the Australian health care system.\u003c\/p\u003e \u003cp\u003eNational level responses to dual diagnosis.\u003c\/p\u003e \u003cp\u003eThe National Comorbidity Initiative.\u003c\/p\u003e \u003cp\u003eImproved Services for People with Drug and Alcohol Problems and Mental Illness Measure.\u003c\/p\u003e \u003cp\u003e‘Can Do’ – Managing Mental Health and Substance Use in General.\u003c\/p\u003e \u003cp\u003ePractice.\u003c\/p\u003e \u003cp\u003eHeadspace.\u003c\/p\u003e \u003cp\u003eState level responses to dual diagnosis.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e20 Dual Diagnosis – Europe \u003ci\u003e(Jane Salvage and Rob Keukens).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eThe historical and social context.\u003c\/p\u003e \u003cp\u003eElements of dual diagnosis in the region.\u003c\/p\u003e \u003cp\u003eAlcohol.\u003c\/p\u003e \u003cp\u003eOther psychoactive substances.\u003c\/p\u003e \u003cp\u003eCare and treatment responses.\u003c\/p\u003e \u003cp\u003eProblems and solutions.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e21 Commissioning Services for Users with Dual Diagnosis \u003ci\u003e(Sharon Dennis).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eBackground.\u003c\/p\u003e \u003cp\u003eThe history of commissioning.\u003c\/p\u003e \u003cp\u003eImplications for commissioning dual diagnosis services.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e22 Practice, Research and Education Development \u003ci\u003e(Kevin Gournay).\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003eResearch.\u003c\/p\u003e \u003cp\u003eEducation development.\u003c\/p\u003e \u003cp\u003ePractice.\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eIndex\u003c\/i\u003e.\u003c\/p\u003e \u003cp\u003e\"This book is a positive contribution to keeping the issues alive and a great resource for clinicians, educationists and researchers in the world of dual diagnosis, who can use it to help them improve users' experiences and the services they receive.\" (\u003ci\u003eMental Health Practice\u003c\/i\u003e, December 2009)\u003c\/p\u003e  \u003cb\u003eDr Peter Phillips\u003c\/b\u003e is Senior Lecturer in Addiction in the Department of Mental Health \u0026amp; Learning Disability at City University London, and Honorary Research Fellow in the Department of Mental Health Sciences, at University College London Medical School. Peter’s background is in low threshold drug services in inner London, and substance use research.\u003cbr\u003e \u003cbr\u003e \u003cb\u003eDr Olive McKeown\u003c\/b\u003e works at St George’s Medical School in London, taking a lead role in under-graduate medical education. She is actively involved in substance misuse and dual diagnosis education within a wide range of medical, nursing and inter-professional programmes\u003cbr\u003e \u003cbr\u003e \u003cb\u003eTom Sandford\u003c\/b\u003e is Director of RCN England and former RCN Advisor on Mental Health.  Tom was previously general manager of mental health services in the London boroughs of Camden and Islington.  \u003ci\u003eDual Diagnosis: Practice in Context\u003c\/i\u003e is a practical evidence-based guide for practitioners working in multi-disciplinary mental health and substance misuse service settings. Divided into three sections, this comprehensive and international text first explores the contemporary contextual issues surrounding the subject area.  It then goes on to review dual diagnosis in some of the ‘special’ populations (including people diagnosed with personality disorders, women, young people, and older adults) and contemporary issues (e.g. crystal methamphetamine and mental health).  \u003cbr\u003e \u003cbr\u003e Part three reviews the development of international service responses to dual diagnosis and discusses the development and commissioning of service models, research and practice development. The text concludes with a chapter outlining priorities for the development of interventions, service approaches, research and education.\u003cbr\u003e \u003cbr\u003e KEY FEATURES:  \u003cul\u003e \u003cli\u003eA authoritative  in-depth review of both theoretical, clinical and policy issues within a single text\u003c\/li\u003e \u003cli\u003eDraws together a range of established contributors from a variety of disciplines, including mental health nurses, occupational therapists, social workers and psychiatrists\u003c\/li\u003e \u003cli\u003eInternational in focus, with contributors from the UK, USA, Europe and Australia\u003c\/li\u003e \u003c\/ul\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989089960165,"sku":"NP9781405180092","price":71.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781405180092.jpg?v=1761782753","url":"https:\/\/k12savings.com\/products\/dual-diagnosis-isbn-9781405180092","provider":"K12savings","version":"1.0","type":"link"}